Cargando…
The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 Outbreak
The coronavirus disease 19 (COVID-19) pandemic poses a serious threat to the sustainability of healthcare systems and is currently having a significant effect on living conditions worldwide. No therapeutic agent has yet proven to be effective for the treatment of COVID-19. The management of this dis...
Autores principales: | Canevelli, Marco, Remoli, Giulia, Trentin, Federica, Riccardi, Gabriele, Tariciotti, Leonardo, Risoleo, Giovanni, Ancidoni, Antonio, Bruno, Giuseppe, Cesari, Matteo, Vanacore, Nicola, Raparelli, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542224/ https://www.ncbi.nlm.nih.gov/pubmed/33072781 http://dx.doi.org/10.3389/fmed.2020.552991 |
Ejemplares similares
-
Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
por: Lacorte, Eleonora, et al.
Publicado: (2022) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021) -
Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease
por: Canevelli, Marco, et al.
Publicado: (2020) -
The Italian national survey on COVID-19 in nursing homes during the first wave of the pandemic
por: Lombardo, Flavia, et al.
Publicado: (2021) -
COVID-19 and dementia: Recommendations from the Italian dementia national plan working group
por: Canevelli, Marco, et al.
Publicado: (2021)